SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193125-15-384052
Filing Date
2015-11-23
Accepted
2015-11-23 09:49:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 PREC14A d98440dprec14a.htm PREC14A 380907
2 GRAPHIC g98440g96q47.jpg GRAPHIC 14795
  Complete submission text file 0001193125-15-384052.txt   403232
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filed by) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-35703 | Film No.: 151248533
SIC: 2834 Pharmaceutical Preparations